Pierrel SpA, the Group is listed on the Italian Stock Exchange since May 2006, is today a global provider of services for the ‘pharmaceutical, bio-pharmaceutical and life science. The Group, through its two business divisions, specializes in pharmaceutical manufacturing (Contract Manufacturing Division), and in the development, registration and licensing of new drugs and medical devices (Pharma Division).